ferral to the first review at the ophthalmic oncology clinic was 17 days. Among the patients, 42.1% had an initial visual acuity of 6/9 or better and 28.8% had an initial visual acuity of 6/60 or worse. The lesion diameter was less than 10 mm (small) for 50.4% of patients, 10 to 15 mm (medium) for 38.3%, and greater than 15 mm (large) for 11.3%. There were 630 interventions, including ruthenium plaque radiotherapy for 51.1%, proton beam radiotherapy for 26.4%, and enucleation for 18.3% (8.2% primary enucleation). Other interventions included cataract surgery, vitrectomy, and local resection. No treatment group was normally distributed (P Ͻ .005). There was no significant difference in the median Scottish Index of Multiple Deprivation scores between the main treatment groups (Kruskal-Wallis P=.91) (Figure) .
We report a case of endogenous GBS endophthalmitis occurring as a presenting sign of precursor T-cell acute lymphoblastic leukemia. To our knowledge, this is the first reported case of acute lymphoblastic leukemia manifesting as GBS endophthalmitis.
Report of a Case.
A 56-year-old man was in good health until developing a febrile illness 6 days prior to his first visit, followed 3 days later by the onset of redness and photophobia in the right eye. He was evaluated for presumed uveitis and treated hourly with topical steroid eyedrops, but he was referred to the uveitis clinic owing to (Figure) . The patient continued to receive parenteral cefotaxime for bacteremia and had systemic chemotherapy initiated by the oncology service, with repeat intravitreous tap and injection of vancomycin 3 days later. Results from the repeat cultures were negative. His visual acuity remained light perception OD 10 days after surgery.
Comment. Endogenous endophthalmitis is a potentially devastating condition characterized by intraocular infection by organisms that access the eye through the bloodstream. Endogenous endophthalmitis accounts for 2% to 6% of all cases of endophthalmitis. 2 In a recent review of cases of endogenous endophthalmitis, GBS was the causative agent in about 5% of cases. 3 Group B Streptococcus most commonly causes infection in neonates and pregnant women, although in the last 2 decades there has been a 2-to 4-fold increase in the incidence of invasive GBS in nonpregnant adults. 4 Most patients with GBS infection have a predisposing condition such as being older than 65 years and having diabetes mellitus, a malignant neoplasm, and compromised immunity. Bacteremia with no evident source of infection is the manifestation of invasive GBS in about 15% of non-pregnant adults. 4 The most common identifiable sources of GBS are skin or soft-tissue infections, urinary tract infections, pneumonia, bone and joint infections, and endocarditis. In a review of cases of GBS endogenous endophthalmitis, most had ocular involvement within 5 days of onset of sepsis, and ocular infection was not the initial manifestation of sepsis in any patient. 1 The visual prognosis in GBS endophthalmitis is poor, with 76% of cases resulting in visual acuity of light perception or worse. 1 Our case is unusual because GBS endophthalmitis was the presenting factor leading to the diagnosis of precursor T-cell lymphoblastic leukemia. This case exemplifies the importance of having a high index of suspicion for endogenous endophthalmitis in uveitis cases with a rapidly progressive course that do not respond to standard therapy with corticosteroids. It also shows the important role an ophthalmologist can play in diagnosing serious underlying medical conditions.
